SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-18-008539
Filing Date
2018-07-16
Accepted
2018-07-16 16:56:31
Documents
8
Period of Report
2018-07-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp93294_8k.htm 8-K 24098
2 EXHIBIT 3.1 dp93294_ex0301.htm EX-3.1 63235
3 EXHIBIT 3.2 dp93294_ex0302.htm EX-3.2 379140
4 EXHIBIT 4.1 dp93294_ex0401.htm EX-4.1 1869
5 GRAPHIC image_002.jpg GRAPHIC 1530
6 GRAPHIC image_003.jpg GRAPHIC 99143
7 GRAPHIC image_006.gif GRAPHIC 143811
8 GRAPHIC image_007.gif GRAPHIC 26488
  Complete submission text file 0000950103-18-008539.txt   843245
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 18954883
SIC: 2834 Pharmaceutical Preparations